All Videos Educational Technical Support Products Customer
Molecular Pathology Reimbursement: Outcome of the 2013 Medicare Gapfilling Process

369 views | 1 decade ago

This webinar summarizes the outcome of the Medicare gapfilling process for 114 new molecular pathology (MoPath) codes that were implemented in 2013. The presentation addresses the final 2013 regional...

Illumina Sequencing Technology

359715 views | 1 decade ago

This video provides an overview of the DNA sequencing workflow on an Illumina sequencer. The process begins with Nextera sample preparation, followed by cluster generation on a system flow cell, sequencing...

October 2013: BaseSpace Worldwide Impact

461 views | 1 decade ago

Starting in early 2012, this video displays a graphical and geographical representation of worldwide BaseSpace uploads on the way to 70,000 runs.

Introducing the Native App Engine in BaseSpace

734 views | 1 decade ago

This video describes the benefits of the BaseSpace Native Apps engine, including the look, feel and behavior of these apps without the need to host your own Web service, and the ability to write and...

Deep Sequencing of HIV Detection of Drug Resistance Variants and Tracking Viral Haplotypes

1148 views | 1 decade ago

This webinar presents insight into the characterization of HIV by next-generation sequencing, including data obtained from a comparison of HIV drug-resistance variant detection in a 465-base region...

For all you seek. Illumina.

1004 views | 1 decade ago

At Illumina, we understand that as a researcher you are unique, and that your research is too. We feel the same way about our company and products. But we all have one thing in common, our drive to...

What is Phasing?

5976 views | 1 decade ago

Whole-genome sequencing conventionally generates a single consensus sequence without distinguishing between variants on homologous chromosomes. Genome phasing addresses this limitation by separating...

Illumina's team of driven individuals makes a difference in the world

11047 views | 1 decade ago

At Illumina, we work on game-changing technologies that benefit human health. Our work contributes to important questions like: "Why is a person more likely to develop Type-2 diabetes?" or "Why do some...